Ally Bridge Group, a private equity firm that invested in Medtech in December 2015, sold its entire stake of the company to Zimmer Biomet for an undisclosed amount.
Medtech currently offers two FDA-approved surgical robots that allow for minimally invasive brain and spine procedures.
Zimmer Biomet expects the acquisition will boost its presence in the musculoskeletal market.
More articles on supply chain:
Philips partners with Life-Assist to boost AED supplies in west coast
CMS, FDA advocate device ID numbers in medical bills and claims
PhRMA adds 5 new companies to its ranks, including generic rival Teva
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
